279 related articles for article (PubMed ID: 11160264)
1. Antigen-specific mediated suppression of beta cell autoimmunity by plasmid DNA vaccination.
Tisch R; Wang B; Weaver DJ; Liu B; Bui T; Arthos J; Serreze DV
J Immunol; 2001 Feb; 166(3):2122-32. PubMed ID: 11160264
[TBL] [Abstract][Full Text] [Related]
2. Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice.
Weaver DJ; Liu B; Tisch R
J Immunol; 2001 Jul; 167(1):586-92. PubMed ID: 11418698
[TBL] [Abstract][Full Text] [Related]
3. More stringent conditions of plasmid DNA vaccination are required to protect grafted versus endogenous islets in nonobese diabetic mice.
Seifarth C; Pop S; Liu B; Wong CP; Tisch R
J Immunol; 2003 Jul; 171(1):469-76. PubMed ID: 12817032
[TBL] [Abstract][Full Text] [Related]
4. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
Tisch R; Wang B; Serreze DV
J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
[TBL] [Abstract][Full Text] [Related]
5. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice.
Tisch R; Wang B; Atkinson MA; Serreze DV; Friedline R
J Immunol; 2001 Jun; 166(11):6925-36. PubMed ID: 11359854
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice.
Gauvrit A; Debailleul M; Vu AT; Sai P; Bach JM
Clin Exp Immunol; 2004 Aug; 137(2):253-62. PubMed ID: 15270841
[TBL] [Abstract][Full Text] [Related]
8. Gene gun-mediated DNA vaccination enhances antigen-specific immunotherapy at a late preclinical stage of type 1 diabetes in nonobese diabetic mice.
Goudy KS; Wang B; Tisch R
Clin Immunol; 2008 Oct; 129(1):49-57. PubMed ID: 18675592
[TBL] [Abstract][Full Text] [Related]
9. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes.
Quinn A; McInerney B; Reich EP; Kim O; Jensen KP; Sercarz EE
J Immunol; 2001 Mar; 166(5):2982-91. PubMed ID: 11207247
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity.
Quintana FJ; Rotem A; Carmi P; Cohen IR
J Immunol; 2000 Dec; 165(11):6148-55. PubMed ID: 11086048
[TBL] [Abstract][Full Text] [Related]
11. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.
Tian J; Atkinson MA; Clare-Salzler M; Herschenfeld A; Forsthuber T; Lehmann PV; Kaufman DL
J Exp Med; 1996 Apr; 183(4):1561-7. PubMed ID: 8666914
[TBL] [Abstract][Full Text] [Related]
12. 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543).
Overbergh L; Decallonne B; Waer M; Rutgeerts O; Valckx D; Casteels KM; Laureys J; Bouillon R; Mathieu C
Diabetes; 2000 Aug; 49(8):1301-7. PubMed ID: 10923629
[TBL] [Abstract][Full Text] [Related]
13. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen.
Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A
J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616
[TBL] [Abstract][Full Text] [Related]
14. Regulatory cytokine production stimulated by DNA vaccination against an altered form of glutamic acid decarboxylase 65 in nonobese diabetic mice.
Glinka Y; De Pooter R; Croze F; Prud'homme GJ
J Mol Med (Berl); 2003 Mar; 81(3):175-84. PubMed ID: 12682726
[TBL] [Abstract][Full Text] [Related]
15. Endogenous expression levels of autoantigens influence success or failure of DNA immunizations to prevent type 1 diabetes: addition of IL-4 increases safety.
Wolfe T; Bot A; Hughes A; Möhrle U; Rodrigo E; Jaume JC; Baekkeskov S; von Herrath M
Eur J Immunol; 2002 Jan; 32(1):113-21. PubMed ID: 11754351
[TBL] [Abstract][Full Text] [Related]
16. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
17. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity.
Quinn A; McInerney MF; Sercarz EE
J Immunol; 2001 Aug; 167(3):1748-57. PubMed ID: 11466400
[TBL] [Abstract][Full Text] [Related]
18. Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD(500-585).
Han G; Li Y; Wang J; Wang R; Chen G; Song L; Xu R; Yu M; Wu X; Qian J; Shen B
J Immunol; 2005 Apr; 174(8):4516-24. PubMed ID: 15814672
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice.
Li AF; Hough J; Henderson D; Escher A
Vaccine; 2004 Apr; 22(13-14):1751-63. PubMed ID: 15068859
[TBL] [Abstract][Full Text] [Related]
20. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes.
Trembleau S; Penna G; Gregori S; Gately MK; Adorini L
Eur J Immunol; 1997 Sep; 27(9):2330-9. PubMed ID: 9341777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
